BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• BioMidwest

  Northwestern Medicine Surgeon First in Illinois to Implant Newly FDA-Approved Milestone Device for Advanced Heart Failure Patients

  Garcia sought a second opinion and from that, became the first patient in Illinois to receive the HeartMate 3 LVAD, a new option for physicians managing advanced heart failure patients in need of short-term hemodynamic support.

  October 30, 2017

   · 

  3 min read
• Business

  Mologic Strengthens Team With the Appointment of Mitch Brooker As General Manager

  Mitch will use his skills and experience to help lead these changes and take products from conception through to manufacture and commercialisation.

  October 30, 2017

   · 

  2 min read
• Business

  Noxxon Releases Interim 2017 Results

  NOXXON Pharma, a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment, has today released its interim 2017 results for the six months to June 30, 2017.

  October 30, 2017

   · 

  7 min read
• Business

  Facilitating A Drug Discovery Ecosystem Genestack Joins The Milner Therapeutics Institute

  Yassin sees increasingly that data needs to be managed across organisational boundaries and between the academic and industry communities, an area where the company has particular strengths.

  October 30, 2017

   · 

  5 min read
• Business

  EXACT Sciences’ Cologuard Revenue Increased 158 Percent to $73M During Third Quarter

  EXACT Sciences today announced that the company generated revenue of $72.6M and completed approximately 161,000 Cologuard tests during the quarter ended Sept. 30, 2017.

  October 30, 2017

   · 

  12 min read
• Business

  Luminex Corporation Reports Third Quarter 2017 Financial Results

  Consolidated revenue of $74.1 million, an increase of 4% compared to the third quarter 2016.

  October 30, 2017

   · 

  25 min read
• Business

  Pfenex to Report Third Quarter 2017 Results and Provide Business Update on Thursday, November 9, 2017

  Pfenex announced today that its third quarter 2017 financial results will be released on Thursday, November 9, 2017, after the market close.

  October 30, 2017

   · 

  2 min read
• Genetown

  Biogen to Present at the Clinical Trials on Alzheimer’s Disease Conference

  Biogen announced today that it will present detailed data from a recently conducted analysis of the long-term extension of its ongoing Phase 1b study of aducanumab at the 10th Clinical Trials on Alzheimer’s Disease Conference meeting in Boston.

  October 30, 2017

   · 

  1 min read
• Business

  PerkinElmer Elects Pascale Witz to Its Board of Directors

  Witz has more than 30 years of global experience, most recently serving as executive vice president, Global Diabetes and Cardiovascular for Sanofi, S.A.

  October 30, 2017

   · 

  2 min read
• Genetown

  Alnylam to Webcast Conference Call Discussing Third Quarter 2017 Financial Results

  Management will provide an update on the Company and discuss third quarter 2017 results as well as expectations for the future via conference call on Tuesday, November 7, 2017 at 4:30 p.m. ET.

  October 30, 2017

   · 

  2 min read